We hypothesized that combination of NOXA and ABT-263 treatment increases cell death by simultaneously inhibiting anti-apoptotic BCL-2 family proteins in HNSCC cells. This evidence concerns the gene PMAIP1 and head and neck squamous cell carcinoma.